BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24395795)

  • 1. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified.
    Movérare-Skrtic S; Börjesson AE; Farman HH; Sjögren K; Windahl SH; Lagerquist MK; Andersson A; Stubelius A; Carlsten H; Gustafsson JÅ; Ohlsson C
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1180-5. PubMed ID: 24395795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone.
    Börjesson AE; Windahl SH; Lagerquist MK; Engdahl C; Frenkel B; Movérare-Skrtic S; Sjögren K; Kindblom JM; Stubelius A; Islander U; Antal MC; Krust A; Chambon P; Ohlsson C
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6288-93. PubMed ID: 21444817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
    Arao Y; Hamilton KJ; Coons LA; Korach KS
    J Biol Chem; 2013 Jul; 288(29):21105-21116. PubMed ID: 23733188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice.
    Börjesson AE; Farman HH; Engdahl C; Koskela A; Sjögren K; Kindblom JM; Stubelius A; Islander U; Carlsten H; Antal MC; Krust A; Chambon P; Tuukkanen J; Lagerquist MK; Windahl SH; Ohlsson C
    J Bone Miner Res; 2013 May; 28(5):1117-26. PubMed ID: 23225083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of estrogen receptor-α and its activation function-1 for growth plate closure in female mice.
    Börjesson AE; Windahl SH; Karimian E; Eriksson EE; Lagerquist MK; Engdahl C; Antal MC; Krust A; Chambon P; Sävendahl L; Ohlsson C
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1381-9. PubMed ID: 22414805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diarylheptanoid phytoestrogens isolated from the medicinal plant Curcuma comosa: biologic actions in vitro and in vivo indicate estrogen receptor-dependent mechanisms.
    Winuthayanon W; Piyachaturawat P; Suksamrarn A; Ponglikitmongkol M; Arao Y; Hewitt SC; Korach KS
    Environ Health Perspect; 2009 Jul; 117(7):1155-61. PubMed ID: 19654927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor α AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators.
    Arao Y; Hamilton KJ; Ray MK; Scott G; Mishina Y; Korach KS
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14986-91. PubMed ID: 21873215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of estradiol are modulated in a tissue-specific manner in mice with inducible inactivation of ERα after sexual maturation.
    Ohlsson C; Farman HH; Gustafsson KL; Wu J; Henning P; Windahl SH; Sjögren K; Gustafsson JÅ; Movérare-Skrtic S; Lagerquist MK
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E646-E654. PubMed ID: 32125882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential SERM effects on corepressor binding dictate ERalpha activity in vivo.
    Webb P; Nguyen P; Kushner PJ
    J Biol Chem; 2003 Feb; 278(9):6912-20. PubMed ID: 12482846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus.
    Scafonas A; Reszka AA; Kimmel DB; Hou XS; Su Q; Birzin ET; Kim S; Chen HY; Tan Q; Roher SP; Dininno F; Hammond ML; Rodan GA; Towler DA; Schmidt A
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):197-206. PubMed ID: 18508261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SERMs have substance-specific effects on bone, and these effects are mediated via ERαAF-1 in female mice.
    Börjesson AE; Farman HH; Movérare-Skrtic S; Engdahl C; Antal MC; Koskela A; Tuukkanen J; Carlsten H; Krust A; Chambon P; Sjögren K; Lagerquist MK; Windahl SH; Ohlsson C
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E912-8. PubMed ID: 27048997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen receptor alpha- and beta-selective substances in the metaphysis of the tibia and on serum parameters of bone and fat tissue metabolism of ovariectomized rats.
    Seidlová-Wuttke D; Prelle K; Fritzemeier KH; Wuttke W
    Bone; 2008 Nov; 43(5):849-55. PubMed ID: 18708178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor α/estrogen receptor β, G protein-coupled estrogen receptor, or estrogen-related receptor γ using fulvestrant (ICI 182780).
    Fitts JM; Klein RM; Powers CA
    J Pharmacol Exp Ther; 2011 Jul; 338(1):246-54. PubMed ID: 21464335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of activating functions 1 and 2 of estrogen receptor α in lymphopoiesis.
    Andersson A; Törnqvist AE; Moverare-Skrtic S; Bernardi AI; Farman HH; Chambon P; Engdahl C; Lagerquist MK; Windahl SH; Carlsten H; Ohlsson C; Islander U
    J Endocrinol; 2018 Feb; 236(2):99-109. PubMed ID: 29255084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AF-1 activation function of estrogen receptor α is necessary and sufficient for uterine epithelial cell proliferation in vivo.
    Abot A; Fontaine C; Raymond-Letron I; Flouriot G; Adlanmerini M; Buscato M; Otto C; Bergès H; Laurell H; Gourdy P; Lenfant F; Arnal JF
    Endocrinology; 2013 Jun; 154(6):2222-33. PubMed ID: 23580568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-nuclear effects of estrogen on cortical bone in males require ERαAF-1.
    Farman HH; Wu J; Gustafsson KL; Windahl SH; Kim SH; Katzenellenbogen JA; Ohlsson C; Lagerquist MK
    J Mol Endocrinol; 2017 Feb; 58(2):105-111. PubMed ID: 28057769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
    Klotz DM; Hewitt SC; Ciana P; Raviscioni M; Lindzey JK; Foley J; Maggi A; DiAugustine RP; Korach KS
    J Biol Chem; 2002 Mar; 277(10):8531-7. PubMed ID: 11751931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes.
    Liu S; Han SJ; Smith CL
    Mol Pharmacol; 2013 May; 83(5):1066-77. PubMed ID: 23462505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
    Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
    Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol.
    Billon-Galés A; Fontaine C; Filipe C; Douin-Echinard V; Fouque MJ; Flouriot G; Gourdy P; Lenfant F; Laurell H; Krust A; Chambon P; Arnal JF
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2053-8. PubMed ID: 19188600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.